Many regenerative medicines seek to provide a transformative and long-lasting effect with a single treatment, potentially enabling a shift from a focus on chronic therapy to possible cures. Patient access to these transformative therapies will be hindered, however, if the health care system is not prepared for the implications of such medical innovation.
This is the third part of an annual review of issues facing the regenerative medicine field by the Alliance for Regenerative Medicine. The first article considered the prospects for...
The current system is organized around paying for chronic interventions based on episodes of care rather than based on value and patient outcomes. The political and payer uproar associated with...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?